沃华医药
(002107)
| 流通市值：32.35亿 | | | 总市值：32.79亿 |
| 流通股本：5.70亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 217,836,836.34 | 763,793,394.09 | 576,678,675.17 | 395,153,676.21 |
| 营业收入 | 217,836,836.34 | 763,793,394.09 | 576,678,675.17 | 395,153,676.21 |
| 二、营业总成本 | 197,061,679.26 | 721,591,576.18 | 554,004,849.28 | 382,920,601.38 |
| 营业成本 | 58,798,116.12 | 209,521,291.37 | 159,899,955.56 | 109,791,991.38 |
| 税金及附加 | 3,669,994.46 | 12,902,286.56 | 9,553,006.4 | 6,291,725.27 |
| 销售费用 | 106,676,380.13 | 388,708,092.15 | 302,748,648.37 | 207,827,860.85 |
| 管理费用 | 18,734,775.31 | 74,667,869.77 | 56,290,696.75 | 41,332,829.13 |
| 研发费用 | 10,272,308.35 | 40,650,174.79 | 29,383,363.35 | 20,635,069.01 |
| 财务费用 | -1,089,895.11 | -4,858,138.46 | -3,870,821.15 | -2,958,874.26 |
| 其中:利息费用 | 19,235.68 | 15,953.21 | 5,816.5 | 5,669.51 |
| 其中:利息收入 | 1,111,686.76 | 4,932,968.75 | 3,915,939.43 | 2,986,818.99 |
| 资产减值损失(新) | -116,084.36 | -1,305,451.05 | -867,044.08 | -936,314.04 |
| 信用减值损失(新) | 4,191,171.55 | -1,856,849.42 | 679,741.77 | 762,050.98 |
| 其他收益 | 1,249,200.19 | 5,546,054.53 | 3,948,480.19 | 2,714,244.83 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 26,099,444.46 | 44,585,571.97 | 26,435,003.77 | 14,773,056.6 |
| 加:营业外收入 | 37,071.5 | 456,979.12 | 262,236.31 | 299,290.68 |
| 减:营业外支出 | 41,486.86 | 2,395,179.81 | 1,526,085.17 | 1,124,823.03 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 26,095,029.1 | 42,647,371.28 | 25,171,154.91 | 13,947,524.25 |
| 减:所得税费用 | 3,982,823.47 | 8,888,830.4 | 5,031,960.61 | 4,328,763.33 |
| 六、净利润 | 22,112,205.63 | 33,758,540.88 | 20,139,194.3 | 9,618,760.92 |
| 持续经营净利润 | 22,112,205.63 | 33,758,540.88 | 20,139,194.3 | 9,618,760.92 |
| 归属于母公司股东的净利润 | 22,859,812.88 | 36,403,379.34 | 22,909,628.29 | 11,081,494.83 |
| 少数股东损益 | -747,607.25 | -2,644,838.46 | -2,770,433.99 | -1,462,733.91 |
| (一)基本每股收益 | 0.04 | 0.06 | 0.04 | 0.02 |
| (二)稀释每股收益 | 0.04 | 0.06 | 0.04 | 0.02 |
| 九、综合收益总额 | 22,112,205.63 | 33,758,540.88 | 20,139,194.3 | 9,618,760.92 |
| 归属于母公司股东的综合收益总额 | 22,859,812.88 | 36,403,379.34 | 22,909,628.29 | 11,081,494.83 |
| 归属于少数股东的综合收益总额 | -747,607.25 | -2,644,838.46 | -2,770,433.99 | -1,462,733.91 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-26 | 2024-08-03 |
| 审计意见(境内) | | 标准无保留意见 | | |